RELUGOLIX WITH ESTRADIOL AND WITH NORETHISTERONE ACETATE

Brand name:

• Ryeqo®

Pharmaceutical company:

Gedeon Richter Australia Pty Ltd

Condition/indication:
(therapeutic use)

• Endometriosis

PBAC Submission type:

New PBS listing (Category 2)

Comment:

--

Public Summary Document:

PBAC Public Summary Documents – March 2024

Related medicines:

--

Submission received for:

March 2024 PBAC meeting

Opportunity for consumer comment:

Open 22/11/2023 and close 31/01/2024 (see PBS Website)

PBAC meeting:

Held on 13/03/2024

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

19/12/2024

Lodgement of required documentation:

11/02/2025

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 12/02/2025

Status:

Finalised

Government processes:

Commenced on 14/02/2025

Medicine listed on the PBS:

01/05/2025 (see PBS schedule)

---